Found "Early HTA": 388 results
Sort by
Relevance

Package of Essential Non-communicable Disease Interventions Economic Evaluation (PEN EE)

In response to the request from Indonesia’s Ministry of Health (MOH), World Health Organization, South East Asia Regional Office (WHO SEARO) commissioned the HITAP International Unit (HIU) to provide support for the Package of Essential Non-communicable (PEN) disease intervention evaluation. The evaluation is predicted to include qualitative anal

iDSI India

This project is part of the international Decision Support Initiative (iDSI), an innovative global partnership between leading government institutions, universities, and think tanks in the field of healthcare priority-setting. iDSI uniquely provides intellectual insight with hands-on field expertise, and delivers peer-to-peer support to policymaker

A situational assessment for the establishment of a Southeast Asia Center for Infectious Disease Control (SEACID)

COVID-19 has shown that irresepctive of national borders, the infectious disease brings multi-dimensional challenges requiring concerted global and regional efforts to address it. In contrast to the European Union and the African Union, the Association of Southeast Asian Nations (ASEAN), the regional cooperation body in Southeast Asia, has had no e

Guide to Health Economic Analysis and Research (GEAR)

GEAR, an international global knowledege effort has been recognised as a platform for making HTA resources available and has proven to be a useful tool for in-country support as indicated by collaborators. This grant period is critical for assessing and ensuring the sustainability of GEAR. The website has been refined to include more material inclu

Health Technology Assessment Development in Bhutan

Bhutan\'s Ministry of Health, especially the Essential Medicine and Technology Division (EMTD), is one of HITAP\'s long-term partners. From 2018 to 2019, HITAP with PATH supported Bhutan to conduct an economic evaluation for the implementation of a national program for rotavirus vaccination. HITAP also provided and continues to find opportunities f

Health Technology Assessment Development in Kenya

HITAP is working with partners to support the Kenyan Ministry of Health to institutionalise health priority setting at the national level of the health system. A relationship between the Kenyan Mininstry of Health and the Thai Ministry of Public Health has been formalised through a memorandum of understanding (MoU). The collaboration focuses on hel

HTA for biologics for non-SJIA

Conducting economic evaluation and budget impact of biologic agents as 2nd-line treatment options for non-systemic juvenile idiopathic arthritis patients who are refractory to 1st-line treatment.Documents

HTA of COVID-19 vaccines in the Philippines

Adapting a dynamic transmission model developed by National University of Singapore to the Philippines context, in order to address policy questions around COVID-19 vaccine choice, target population for booster doses, and the impact of social gatherings on COVID-19 spread.

HTA of COVID-19 vaccines in Thailand

To calibrate the Covid M SEIR model to Thailand and to build capacity to use the model to address policy questions in Thailand. This project will address COVID-19 vaccination policy questions, such as frequency and target population for booster doses, as well as development of web-based applications to communicate the results to policymakers and ot

Indonesia

Providing technical support on HTA studies and support with capacity building through knowledge exchange.
10 / Page